Caxton Corporation’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,015,157
| Closed | -$6.83M | – | 15 |
|
|
2024
Q4 | $6.83M | Sell |
2,015,157
-3,098,191
| -61% | -$10.5M | 41.06% | 1 |
|
|
2024
Q3 | $14.6M | Hold |
5,113,348
| – | – | 60.31% | 1 |
|
|
2024
Q2 | $11.5M | Hold |
5,113,348
| – | – | 58.31% | 1 |
|
|
2024
Q1 | $11.3M | Sell |
5,113,348
-528,572
| -9% | -$1.17M | 64.38% | 1 |
|
|
2023
Q4 | $13.3M | Hold |
5,641,920
| – | – | 71.57% | 1 |
|
|
2023
Q3 | $10.5M | Hold |
5,641,920
| – | – | 39.87% | 2 |
|
|
2023
Q2 | $14.8M | Sell |
5,641,920
-397,108
| -7% | -$1.04M | 42.66% | 2 |
|
|
2023
Q1 | $9.84M | Hold |
6,039,028
| – | – | 24.86% | 2 |
|
|
2022
Q4 | $8.03M | Hold |
6,039,028
| – | – | 20.52% | 2 |
|
|
2022
Q3 | $9.42M | Hold |
6,039,028
| – | – | 17.72% | 2 |
|
|
2022
Q2 | $9.3M | Hold |
6,039,028
| – | – | 12.49% | 2 |
|
|
2022
Q1 | $15.5M | Sell |
6,039,028
-271,518
| -4% | -$695K | 19.22% | 1 |
|
|
2021
Q4 | $18.5M | Buy |
+6,310,546
| New | +$18.5M | 15.11% | 1 |
|